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Microglia play critical roles in neural development and homeostasis. They are also implicated 43 
in neurodegenerative and neuroinflammatory diseases of the central nervous system (CNS). 44 
However, little is known about the presence of spatially and temporally restricted subclasses 45 
of microglia during CNS development and disease. Here, we combined massively parallel 46 
single-cell analysis, single-molecule FISH, advanced immunohistochemistry and 47 
computational modelling to comprehensively characterize novel microglia subclasses in up to 48 
six different regions during development and disease. Single-cell analysis of mouse CNS 49 
tissues revealed specific time- and region-dependent microglia subtypes, which were 50 
transcriptionally distinct from perivascular macrophages, during homeostasis. Demyelinating 51 
and neurodegenerative diseases evoked context-dependent microglia subtypes with distinct 52 
molecular hallmarks and diverse cellular kinetics. Diverse microglia clusters were also 53 
identified in normal and diseased human brains. Our data provide new insights into the 54 
endogenous immune system of the CNS during development, health and disease.    55 
 56 
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Tissue-resident myeloid cells in the central nervous system (CNS) represent a 64 
heterogeneous class of innate immune cells that are essential for the maintenance of tissue 65 
homeostasis (1). Parenchymal microglia and the CNS-associated macrophages (CAMs), 66 
including leptomeningeal (mMΦ), perivascular (pvMΦ) and choroid plexus macrophages 67 
(cpMΦ), are the organ-specific macrophages of the CNS with pivotal roles in health and 68 
disease (2-4).  69 
Despite of the similarities that microglia and CAMs share with various other tissue-resident 70 
macrophages, the parenchymal and non-parenchymal CNS macrophages have two 71 
distinctive properties, namely a restricted prenatal origin and a remarkable longevity (4, 5). It 72 
is now generally believed that microglia and CAMs are derived from early yolk sac 73 
erythromyeloid precursors in a c-myb- and chemokine receptor (CCR)2-independent fashion 74 
(6-8). These specific developmental pathways and anatomical niches make CNS-75 
endogenous macrophages distinct from other tissue macrophages, such as those in the 76 
aorta, skin, heart, liver, spleen and other organs (9-12). 77 
When compared to other hematopoietic cells, microglia and CAMs persist over a very long 78 
period of time with low but constant rates of self-renewal (13, 14) coupled to cell apoptosis 79 
(15). This longevity necessitates adaptivity of microglia towards environmental challenges 80 
(16, 17) and cell perturbations (18). Since microglia act as guardians of the CNS, 81 
continuously scavenging for dying cells, pathogens, and molecules through microbial-82 
associated molecular pattern receptor-dependent and -independent mechanisms (1), these 83 
highly diverse and specialized functions may be executed by microglia subsets that already 84 
pre-exist in situ, or alternatively, by specific development of microglia subsets from a 85 
homogeneous pool of cells upon demand. To date, the spatiotemporal heterogeneity of 86 
microglia during development, homeostasis and disease has not been studied at the single-87 
cell level.  88 
Previous approaches used to analyse microglial diversity have largely relied on 89 
immunophenotyping by flow cytometry complemented with histological analysis of RNA and 90 
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proteins in situ (19, 20). More recently, comprehensive transcriptomic (21) and proteomic 91 
(22) profiling of bulk populations of large numbers of microglia helped to reveal microglial 92 
heterogeneity in the mouse brain. Indeed, different microglia states were identified during 93 
development (7, 12, 23-25), homeostasis (26) and disease (27). Although these approaches 94 
provided important insights, they have notable limitations. Earlier single-cell analyses of 95 
microglia, for instance via flow cytometry, in situ hybridization or immunohistochemistry, were 96 
limited to probing a few selected proteins or RNAs. Due to a bias toward candidate 97 
genes/proteins, these approaches allow neither analysis of comprehensive expression 98 
landscapes nor discovery of previously unrecognized molecules (28). In contrast, 99 
transcriptomic analysis of bulk preparations of microglial RNA may conceal the diversity of 100 
microglia across different brain regions by relying on ensemble averages (21, 29, 30). 101 
During the last few years, the revolution in single-cell genomics has enabled an unbiased 102 
genome-wide quantification and multiplex spatial analysis of RNA in single microglia in situ 103 
as well as in vitro (31). However, recent single-cell RNA-sequencing (scRNA-seq) studies of 104 
microglia either only used pre-sorted myeloid cell populations (32), or whole brain 105 
approaches (33) without addressing the question of spatially and temporally restricted 106 
subtypes of microglia in several regions of the CNS. Importantly, single-microglia profiling 107 
data from humans is not yet available at all, although this knowledge may greatly improve 108 
our understanding of the pathogenesis of neuropsychiatric diseases. 109 
By combining massively parallel scRNA-seq with single-molecule FISH (smFISH), advanced 110 
triple immunohistochemistry, high-resolution microscopy, and computational modelling, we 111 
were able to comprehensively characterize microglial diversity in different regions of the 112 
mouse and human brain during development and health. We identify molecules that 113 
characterize microglial populations involved in neuroinflammatory and neurodegenerative 114 
conditions in mice and humans, and highlight context- and time-dependent microglia subsets 115 
and their distinct signals. The data provide new potential therapeutic targets and a valuable 116 
resource for the study of disease mechanisms in the CNS.  117 
 118 
119 





Distinct cell-specific signatures of individual microglia and pvMΦ in the juvenile 122 
mouse brain 123 
We first used an unbiased, surface marker-free approach to study the complexity of the CNS 124 
of prepubescent juvenile mice and to determine how transcriptionally dissimilar microglia and 125 
pvMΦ are as compared to the other CNS cells. For this purpose, we prepared a CNS cell 126 
suspension devoid of meninges and choroid plexus (Fig. 1a). We then performed 127 
quantitative scRNA-seq of 3,047 CNS cells as described before (34). Individual RNA 128 
molecules were counted using molecular identifiers (UMIs) as performed recently (8, 34), 129 
which greatly reduces PCR amplification bias. 130 
Dimensionality reduction using t-distributed stochastic neighbor embedding (t-SNE) revealed 131 
that both microglia and pvMΦ were transcriptionally related, whereas neurons, 132 
oligodendrocytes, astrocytes, endothelial cells and vascular smooth muscle cells (VSMC) 133 
had a distinct RNA profile (Fig. 1b). In order to define the transcriptional differences that 134 
allow for the distinction of cell types in the CNS, we generated a heat map from 2,996 single 135 
sorted cells showing the 49 most variable genes (Fig. 1c). Microglia and pvMΦ shared some 136 
markers like Aif1, Csf1r and Tyrobp (Extended Data Fig. 1a), but microglia were 137 
distinguishable from pvMΦ and other CNS cells on the basis of their expression of Tgfbr, 138 
Gpr34, Hexb, Selplg, Il1a (Fig. 1c). In contrast, pvMΦ expressed higher mRNA levels of 139 
Folr2, Lyve1, F13a1, Cbr2, Mrc1, Pf4, Cd163, Ccl24 and Cd209f. Gene ontology (GO) 140 
analysis comparing gene expression profiles of microglia and pvMΦ suggested functional 141 
involvement of microglia in cell chemotaxis, inflammatory response and regulation of cell 142 
adhesion, whereas pvMΦ were involved in inflammatory response, regulation of response to 143 
external stimulus, endocytosis and cytokine production (Extended Data Figs. 1b, c). 144 
Visualization of scRNA-seq data on t-SNE plots revealed that microglia and pvMΦ 145 
populations are distinguishable based on their transcriptomic signature (Fig. 1d). Taken 146 
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together, these data reveal that microglia and pvMΦ  are transcriptionally distinct myeloid cell 147 
populations in the CNS.  148 
 149 
Comprehensive transcriptome analysis microglia during development, homeostasis 150 
and disease by single-cell RNA-sequencing 151 
Recent whole transcriptome analysis of microglia development from yolk sac progenitors to 152 
adult microglia highlighted the degree to which cells change during this interval, showing 153 
dramatic differences in microglial gene expression between early postnatal periods and 154 
adulthood (7, 12, 25). However, it is still unknown whether microglia subclasses with distinct 155 
transcriptional profiles emerge during development. In order to study microglia heterogeneity 156 
on single-cell level during different homeostatic conditions, we collected single microglia cells 157 
from multiple anatomical regions of the embryonic (embryonic day E16.5), juvenile (3 weeks) 158 
and adult (16 weeks) mouse CNS (Fig. 2a). The areas were selected to match those 159 
previously found to exhibit transcriptional differences of microglial bulk RNA on Affymetrix 160 
analysis (21). To further compare expression patterns during homeostasis to those under 161 
pathological conditions, microglia were also isolated from neurodegenerative (facial nerve 162 
axotomy) and demyelinating (cuprizone paradigm) disease models (Fig. 2a). In order to 163 
increase the yield, microglia were FACS-sorted from four different CNS regions during 164 
embryogenesis and up to six different CNS regions for postnatal time points (Fig. 2a and 165 
Suppl. Fig. 1). Following quality control, data from a total of 3,826 single microglia were 166 
further analyzed using the RaceID algorithm (Herman JS, 2018) and finally depicted in t-SNE 167 
plots (Fig. 2b and Suppl. Fig. 2). Unsupervised clustering gave rise to 13 distinct clusters, 168 
resembling ten microglia clusters during development (C1-C10) and one cluster for 169 
degeneration (C11) and two clusters for demyelination and remyelination (C12 and C13) 170 
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Spatiotemporal specificity of the emergence of microglia subsets during development  175 
To investigate microglia diversity during development, we first focused on microglia from 176 
non-diseased CNS regions. t-SNE plots visualized two main clouds that clearly segregate 177 
embryonic and postnatal microglia (Fig. 3a). Unbiased clustering of the top differentially 178 
regulated genes revealed the presence of ten major clusters of microglia (C1-10) with distinct 179 
transcriptional profiles (Figs. 3b, c and Suppl. Fig. 3). Among them, the C1-6 clusters 180 
predominantly consisted of embryonic microglia, whereas the postnatal microglia constituted 181 
C7-10 clusters (Figs. 3a, b). Notably, embryonic clusters (C1-6) were differently distributed 182 
across the four embryonic CNS regions tested (Figs. 3d, e). For instance, the C2 cluster was 183 
enriched in embryonic forebrain and midbrain, whereas the C6 microglia was predominantly 184 
observed in cerebellum and spinal cord (Figs. 3d, e). Likewise, the postnatal clusters 185 
showed a spatiotemporally variable distribution. For example, , e.g. the C10 cluster was 186 
enriched in juvenile cortical and hippocampal microglia (86.0 % and 71.7 % of microglia in 187 
the cortex and in the hippocampus, respectively, compared to 25.7 % in the cerebellum, 188 
Figs. 3d, e). Furthermore, the minor C7 cluster was more prevalent in cerebellum and 189 
corpus callosum during adulthood (for both regions 12.3 % and 8.9 % of microglia in the 190 
cerebellum and in the corpus callosum compared to 5.6 % in the cortex). The relative 191 
proportion of clusters in the cerebellum didn´t change between the juvenile and the adult 192 
stages, which is in sharp contrast to what was observed in the cortex and hippocampus, 193 
where the C10 microglia decreased at the expense of the C7 and C8 clusters in adulthood 194 
(Figs. 3d, e). Overall, adult microglia showed a more homogenous distribution of each 195 
cluster across regions than juvenile microglia (Figs. 3d, e). Together, these data suggest 196 
that microglia exhibit different subtypes with distinct gene expressional profiles over the 197 
course of development with strong variation between different CNS regions that might reflect 198 
local maturation differences.  199 
Among the top differentially regulated genes during development were the microglial 200 
homeostatic genes Tmem119, Selplg and Slc2a5, which were highly induced at postnatal 201 
stages (Fig. 4a). In addition, expression of Malat1, a long non-coding RNA, increased during 202 
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development, with the highest expression levesl being observed in adult microglia (Extended 203 
Data Figs. 2a, b). In the embryonic clusters, lysosome-related genes Ctsb (encoding 204 
cathepsin B), Cstd (encoding cathepsin D), Lamp1 (lysosomal-associated membrane protein 205 
1), were strongly induced in C1 and C2 microglia (Fig. 3b and Extended Data Fig. 2c), 206 
suggesting enhanced lysosomal activity in these embryonic microglia. In contrast, expression 207 
of Apoe, which encodes the myeloid cell activation marker apolipoprotein E (27), was 208 
enriched in the C1, C4 and C5 clusters (Fig. 4b). C6 microglia were characterized by high 209 
expression levels of Tmsb4x (encoding thymosin beta 4), Eef1a1, and Rpl4 (Fig. 4b and 210 
Extended Data Fig. 2d), We next confirmed the existence of APOE+Iba1+ microglia and 211 
CTSB+Iba1+ microglia in the embryonic forebrain and cerebellum on a protein level by triple 212 
immunofluorescence staining (Fig. 4c). These distinct embryonic microglia subpopulations 213 
disappeared in the juvenile and adult brains (Figs. 4c, d). On the other hand, postnatal C9 214 
and C10 microglia clusters were characterized by high expression of Cst3 (encoding cystatin 215 
C, a cysteine protein proteinase inhibition family involved in neurodegenerative diseases of 216 
the CNS (36)), and Sparc (encoding secreted protein acidic and rich in cysteine; also known 217 
as osteonectin) (Fig. 4e). Immunolabeling for CST3 and SPARC confirmed the presence of 218 
CST3+SPARC+Iba1+ microglia in the postnatal brains, whereas this population was virtually 219 
absent in embryonic forebrains (Figs. 4f,g). Interestingly, expression of CST3 was also 220 
detectable in a subpopulation of Aldh1l1+ astrocytes in the adult cerebral cortex (Extended 221 
Data Fig. 3). In contrast to the juvenile cerebral cortex, where almost all microglia expressed 222 
CST3 and SPARC (Figs. 4f, g), the abundance of this microglia subpopulation slightly 223 
diminished in the adult cortex, as CST3-SPARC+Iba1+ microglia emerged (Fig. 4g). In 224 
contrast, the proportion of CST3+SPARC+Iba1+ microglia did not change between the 225 
juvenile and adult cerebellum (Fig. 4g), although the overall percentage of SPARC-226 
expressing microglia was lower in the cerebellum than in cortex, and CST3+SPARC-Iba1+ 227 
microglia made up a significant fraction of juvenile and adult cerebellar microglia (Fig. 4g). 228 
Taken together, our data identify novel markers of microglia subsets and demonstrate the 229 
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spatiotemporal and phenotypic diversity of microglia subsets during CNS development and 230 
homeostasis in the adult brain. 231 
 232 
Identification of microglia clusters unique to demyelination and different from 233 
neurodegeneration  234 
To investigate the kinetics of homeostatic microglia clusters and the putative generation of 235 
disease-specific microglia populations during CNS pathology, we compared a model of toxic 236 
demyelination, the cuprizone model, with a paradigm of neurodegeneration, the unilateral 237 
facial nerve axotomy (FNX) lesion (Fig. 2a). The blood–brain barrier remains intact in both 238 
models, and a loss of oligodendrocytes in the corpus callosum or a remote 239 
neurodegeneration within the facial nucleus, respectively, lead to local microglial activation 240 
without recruitment of circulating monocytes (13, 37). The two models allow us to study 241 
microglial plasticity following withdrawal of cuprizone or axonal regeneration, respectively 242 
(Fig. 2a). 243 
On the t-SNE plot, microglia distributed uniformly in a major population, but cells that 244 
clustered separately were found 3 days after FNX, and in the 5- and 10-week groups of 245 
cuprizone treatment (Fig. 5a-c). The C11-13 microglia predominantly constituted the 246 
disease-associated separate clouds on the t-SNE map (Fig. 5c). Notably, the C11 microglia 247 
cluster was specific to neurodegeneration, whereas demyelination induced the disease-248 
specific clusters (C12 and C13) (Figs. 5d-f). In the FNX model, the 3-day time point revealed 249 
a distinct microglia cluster (C11) characterized by stron expression of Ctsc (encoding 250 
cathepsin C) (Fig. 5e), whereas microglia from the 14-day time point clustered with the 251 
homeostatic microglia population. In contrast, toxic demyelination induced long-lasting 252 
transcriptional changes that only slightly recovered at the 10-week time point (Fig. 5f). In 253 
sum, our data suggest that homeostatic microglia are able to quickly change their phenotype 254 
and gain a discrete context- and time-dependent signature.  255 
When analyzing the data for disease-specific signatures in microglia, a strong upregulation of 256 
Apoe was noted at all time points after cuprizone treatment (Fig. 5g). Cst7 was more 257 
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prevalent in the demyelination-associated microglia (C12) (Fig. 5g), and Cybb was more 258 
strongly induced in the remyelination-associated C13 cluster  (Fig. 5h and Extended Data 259 
Fig. 4g). In addition to Apoe, genes for Axl, Igf, Lyz2, Itgax (encoding CD11c), Gpnmb and 260 
Apoc1 were induced during de- and remyelination (Extended Data Fig. 4a), whereas 261 
Fam20c, Cst7, Ccl6, Fn1, Ank, Psat1 and Spp1 were enriched to variable degrees in the 262 
demyelination-associated C12 microglia (Figs. 5g,h and Extended Data Figs. 4b, c, e). In 263 
contrast, the remyelination-associated C13 microglia was characterized by high expression 264 
levels of the MHC class II genes Cd74, H2-A2 and H2-Ab1 (Fig. 5h and Extended Data Fig. 265 
4i). On the other hand, the microglial core marker Tmem119 was down-regulated following 266 
cuprizone treatment (Fig. 5h). Single-molecular fluorescence in situ hybridization (smFISH) 267 
validated the disease-associated expression of Fn1, Spp1, Cybb transcripts in Cx3cr1-268 
expressing microglia (Extended Data Figs. 4d, f, h). Furthermore, demyelination-associated 269 
microglia subtype (SPP1+CD74-Iba1+ and TMEM119-CD74-Iba1+) was confirmed on the 270 
protein level by triple immunofluorescence staining (Figs. 5i,j). Likewise, remyelination-271 
associated microglia subtype (SPP1-CD74-Iba1+ and TMEM119-CD74+Iba1+) was confirmed 272 
by triple immunofluorescence staining (Figs. 5i,j). Overall, our results suggest the 273 
emergence of unique microglia subpopulations characterized by distinct signatures under 274 
defined disease conditions. 275 
 276 
Microglial diversity in the human brain    277 
 In order to extend our studies of microglial heterogeneity from mice to humans, we next 278 
analyzed 1,180 cortical microglia isolated from surgically resected human brain tissue 279 
without histological evidence of CNS pathology (referred to as “healthy”) from five adult 280 
individuals with aged 23 to 54 years (Suppl. Table. 1). Unbiased hierarchical clustering of 281 
individual human microglia revealed four major clusters, hereafter referred to as healthy 282 
human clusters (HHu-C) (Figs. 6a-c and Extended Data Fig. 5). Detailed analysis of 283 
differentially regulated genes across the human microglia clusters revealed similarities with 284 
the gene expression profiles of murine homeostatic microglia. For example, CST3 (enriched 285 
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in mouse clusters C9 and C10) was more highly expressed in HHu-C1 and HHu-C2 than in 286 
HHu-C3 and HHu-C4 (Figs. 6b, d). In contrast, the human microglia cluster HHu-C4 showed 287 
comparatively high expression of the chemokine genes CCL4 and CCL2, and the zinc finger 288 
transcription factors EGR2 and EGR3 (Figs. 6b, d). Interestingly, CCL4 mRNA was rarely 289 
expressed in murine microglia even after cuprizone treatment (Extended Data Fig. 4j). 290 
Notably, P2RY13 mRNA was highly expressed by human microglia HHu-C1 and HHu-C2 291 
clusters (Fig. 6b, Extended Data Fig. 5c), whereas the gene was not differentially 292 
expressed by murine adult microglia at single-cell level. In sum, our analysis identified 293 
homeostatic human microglia states with distinct gene expression patterns that partially 294 
overlap with adult mouse microglia.  295 
Activated microglia have been implicated in disease progression of multiple sclerosis (MS), a 296 
debilitating neurological disorder associated with demyelination (38). To examine the 297 
presence of disease-specific microglia subpopulations during this pathology in humans, 422 298 
CD45+ cells isolated from the brains of five patients with histologically confirmed early active 299 
MS (Extended Data Fig. 6) were subjected to scRNA-seq and subsequently analysed 300 
together with healthy human microglia (Figs. 6e-j). Unsupervised clustering grouped cells 301 
into ten transcriptionally different clusters, which we termed human clusters (Hu-C)1-10 302 
(Figs. 6f-h). Among them, the transcriptome of the Hu-C1 population showed a strong 303 
lymphocyte signature (TRAC, TRBC2, CD52, and IL32) (Fig. 6i), and the Hu-C9 and Hu-C10 304 
populations were characterized by a clear monocytic profile (PLAC8, S100A9, CLEC12A, 305 
and CCR2) (Fig. 6i);  these clusters were therefore excluded from further analysis. The 306 
remaining seven myeloid clusters, Hu-C2-8, expressed microglial core genes such as 307 
TMEM119, P2RY12, CX3CR1, SLC2A5 and P2RY13 to variable degrees (Fig. 6g). The Hu-308 
C5-7 microglia clusters, which consisted entirely of microglia from healthy brains, showed 309 
highest expression levels of the microglial core genes and were therefore considered to 310 
represent the homeostatic microglia states (Figs. 6h, j and Extended Data Fig. 7a). 311 
Interestingly, the Hu-C4 subset that was shared by microglia from the healthy and diseased 312 
human brains revealed reduced expression levels of the core signature genes, but elevated 313 
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levels of CCL2, CCL4, EGR2 and other chemokine/cytokine genes, suggesting a pre-314 
activated state of these microglial cells (Figs. 6h, j and Extended Data Fig. 7d). Unbiased 315 
clustering further identified two MS-enriched microglia clusters (Hu-C3 and Hu-C8) and one 316 
MS-associated microglia cluster (Hu-C2) that were clearly separated from the homeostatic 317 
clouds on t-SNE plots (Figs. 6e, f, h, j). The microglia clusters Hu-C2, Hu-C3 and Hu-C8 318 
showed increased expression of APOE and MAFB (Extended Data Fig. 7f), whereas the 319 
core microglial genes were down-regulated or absent (Fig. 6j). Immunofluorescence staining 320 
of tissue from MS patients confirmed the strong reduction of TMEM119 expression on 321 
microglia in demyelinating lesions (Fig. 6k). The MS-associated Hu-C2 microglia was 322 
characterized by high expression levels of CTSD, APOC1, GPNMB, ANXA2, FAM20C and 323 
LGALS1 genes (Fig. 6j and Extended Data Fig. 7b, f). The Hu-C3 microglia showed 324 
increased gene expression of MHC class II-related molecules, such as CD74, HLA-DRA, 325 
HLA-DRB1 and HLA-DPB1 (Fig. 6j and Extended Data Fig. 7c). This suggests an 326 
immunoregulatory role, reminiscent of the remyelination-associated microglia subtype (C13) 327 
in mice (Fig. 5). Finally, the Hu-C8 microglia showed strong expression of SPP1, PADI2 and 328 
LPL genes, similar to the demyelination-associated microglia subtype (C12) in mice (Figs. 329 
6g, j and Extended Data Fig. 7e). Of note, pairwise correlation analysis of mouse and 330 
human microglia orthologs confirmed that human MS-associated/-enriched microglia clusters 331 
(Hu-C2, Hu-C3 and Hu-C8), but not the pre-activated Hu-C4 cluster, are transcriptionally 332 
correlated to mouse demyelination-associated (C12) and remyelination-associated (C13) 333 
microglia observed after cuprizone treatment (Extended Data Fig. 8)   334 
To validate our scRNA-seq results for human microglia from MS patients, we performed 335 
immunohistochemical staining of MS brain sections. First, we stained for MRP14, which is 336 
known to label infiltrating monocytes but not microglia in early active lesions (39). Human 337 
brain sections without CNS pathology were virtually devoid of MRP14+Iba1+ cells, whereas 338 
12 % of all Iba1+ cells in the MS sections were infiltrating monocytes (healthy: 0.2 ± 0.2 %, 339 
MS: 11.6 ± 2.4 %, Fig. 6l). However, this indicates that the vast majority of Iba1+ myeloid 340 
cells present in these sections were resident human MRP14-Iba1+ microglia. Next, we 341 
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performed triple immunofluorescence staining and identified CTSD+MRP14-Iba1+, 342 
SPP1+MRP14-Iba1+ and CD74+MRP14-Iba1+ microglia subsets as part of the Hu-C2, Hu-C8 343 
and Hu-C3 clusters in brain sections from MS patients (Figs. 6m, n). In contrast to the 344 
mouse cuprizone-induced demyelination model, the proportion of SPP1-, CTSD- and CD74-345 
expressing microglia subsets varied substantially between individual MS patients (Figs. 6m, 346 
n), indicating high inter-individual heterogeneity. Together, these findings suggest the 347 
existence of distinct disease-related microglia subtypes in the brains of MS patients, which 348 
are phenotypically similar to murine microglia subtypes in a demyelination model. 349 
  350 




Our study provides a high-resolution view of the transcriptional landscape of microglia 352 
subtypes across multiple regions of the adult murine CNS. Furthermore, our data reveal a 353 
transcriptional continuum between microglia states, with few pre-existing clusters under 354 
homeostatic conditions after birth. Initial cell-specific states were rather uniform throughout 355 
the CNS during adulthood. In contrast, microglia subtype specification after birth emerged in 356 
a region- and disease stage-specific manner with high plasticity (Extended Data Fig. 9). 357 
Each brain region appears to be subject to changes in its immunological status, as revealed 358 
by regionally distinct states of mature microglia. In fact, classical monogenetic 359 
microgliopathies, such as hereditary diffuse leukoencephalopathy with spheroids (HDLS), 360 
Nasu-Hakola disease and others, are characterized by variable regional pathologies, 361 
suggesting diversity and differential spatial vulnerability of microglia (4, 36). Our data also 362 
reveal considerable dynamics of microglia subsets during development. It has been 363 
suggested that microglia ontogeny follows a defined stepwise transcriptional program to 364 
achieve the full homeostatic signature after birth (7, 25, 40). Indeed, we observed that 365 
microglia core genes like Tmem119, Selplg and Slc2a5 are abundantly expressed only 366 
during adulthood. Since their expression levels increase after birth, it is tempting to speculate 367 
that microglia from juveline might not yet have fully matured. Interestingly, the embryonic 368 
microglia clusters were characterized by high expression of ApoE (C1, C4 and C5) and Ctsb 369 
(encoding cathepsin B) (C1 and C2), suggesting increased microglial activation and 370 
phagocytic–lysosomal activity. The developmental upregulation of cathepsin B, a protease 371 
activates matrix metalloproteinases (MMPs) and is thereby essential for the proteolysis of 372 
extracellular matrix components, might facilitate microglial movement in the growing brain, 373 
which depends on MMP8 and MMP9 in vivo (7). The widespread presence of cathepsin B+ 374 
microglia across different regions of the developing forebrain and cerebellum suggests a 375 
general function of these proteins in embryonic microglia. Furthermore, differential 376 
enrichment of microglial clusters across CNS regions during development might reflect 377 
distinct maturation stages of these regions.   378 
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Previous studies on regional variations in microglial density (41), surface expression of a 379 
small panel of immune molecules (20), dependency on interleukin-34 (42), and microarray 380 
analysis of microglial bulk RNA (21) suggested diversity of microglia. However, earlier 381 
studies based on analysis of bulk cell populations isolated using a small set of surface 382 
markers were limited in their resolution of the heterogeneity and complexity of CNS immune 383 
cells. scRNA-seq enables unbiased characterization of small cell populations, and was used 384 
here to generate a high-resolution picture of microglia heterogeneity in the mouse and 385 
human brain. Single-cell analysis can also help to identify novel markers, pathways and 386 
regulatory factors that are critical during CNS development, homeostasis and disease. For 387 
example, in a recent study combining fate mapping and scRNA-seq, we showed that CAMs, 388 
like pvMΦ, are ontogenetically closely related to microglia (8). Despite their ontogenetic 389 
resemblance, this study revealed that microglia and pvMΦ are transcriptionally distinct 390 
myeloid cell populations in the CNS. Whether microglia and CAMs also originate from distinct 391 
progenitor populations in the yolk sac needs to be elucidated in the future.  392 
A recent study proposed regional differences in deep brain murine microglia, such as those 393 
within the basal ganglia (43). Microglia from the nucleus accumbens, ventral tegmental area 394 
and other regions were found to differ in morphology, density and membrane properties. 395 
Whether the observed differences in the membrane properties of microglia subsets within 396 
basal ganglia are functionally relevant remains unclear. Notably, morphological differences of 397 
microglia were accompanied by variations of cell density, with highest numbers of microglia 398 
in the midbrain and basal ganglia, as has been described previously (41). These region-399 
specific features might be due to the specific local microenviroment. In our study, we used 400 
scRNA-seq to investigate different CNS regions (excluding the basal ganglia) in the adult 401 
mouse brain that are known to exhibit microglia with diverse morphological features; however 402 
we did not observe obvious changes at the transcriptional level. The only exception was an 403 
enrichment of the C7 and C8 clusters in the cerebellum. Notably, the expression of Sparc, 404 
one of the representative genes that can segregate postnatal microglia states, was lower in 405 
cerebellar microglia compared to their cortical counterparts. These findings are in line with 406 
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Affymetrix analyses that suggested heterogeneity of murine cerebellar microglia (21). 407 
Moreover, recent single-nuclei sequencing of striatal and cerebellar microglia from adult mice 408 
revealed epigenetic regulation of microglia clearance activity, with highest clearance 409 
activities in cerebellar microglia (Ayata 2018).  410 
Previous single-cell analyses identified neurodegeneration-associated microglia subsets in 411 
mice (27, 32, 33), but deyelination- and remyelination-associated microglia subsets were 412 
never examined at the single-cell level before. Here, we provide evidence for highly 413 
specialized and distinct demyelination- and remyelination-associated microglia subtypes in 414 
mice. Notably, we detected transcriptionally similar microglia subclasses in brain tissue from 415 
human MS patients, suggesting conserved responses to CNS demyelination. Since microglia 416 
down-regulate the expression of core genes during inflammatory conditions, we took 417 
advantage of the recently established microglia markers, TMEM119 and P2Y12R, that allow 418 
for the distinction of human microglia from infiltrating monocytes (44, 45). Our findings 419 
suggest that the highly specialized MS-associated human microglia subpopulations are 420 
characterized by enriched expression of SPP1, CTSD and the MHC class II-related molecule 421 
CD74, providing potential novel targets for MS therapy.  422 
Taken together, our study provides the first in vivo comparison of microglia heterogeneity at 423 
a single-cell resolution in the mouse and human CNS. Although we detected transcriptionally 424 
distinguishable microglia subpopulations, these did not appear as distinct clusters but rather 425 
as a transcriptional continuum of the local microglia population. This might represent the 426 
transcriptional basis for the ability of microglia to swiftly adapt to environmental changes. Our 427 
data further indicate that microglial responses to pathology are not uniform, but are shaped 428 
by the underlying pathology. In fact, we found disease-associated microglia subtypes in mice 429 
and humans that differed between neurodegenerative conditions (such as FNX) and toxic 430 
demyelination (like cuprizone). The appearance of context-dependent microglia subtypes 431 
with their own specific transcriptional profiles has potential therapeutic implications. 432 
Moreover, by establishing the transcriptional profile of heterogenous microglia populations in 433 
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healthy and diseased rodents and humans, our study may provide new insights into the 434 
pathogenesis of CNS diseases. 435 
436 
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MATERIAL AND METHODS 461 
Mice: CD1 mice were used. All animal experiments were approved by local administration 462 
and were performed in accordance to the respective national, federal and institutional 463 
regulations. Detailed mouse information is provided in Suppl. Table 1. 464 
Analysis of single cell gene expression in diverse CNS cell types: A CNS cell 465 
suspension was obtained from a thorough preparation of eight different regions of the 466 
juvenile brain (mixed gender) in which meninges and choroid plexus were removed before. 467 
Cells were then subjected to single-cell RNA-seq using the C1 AutoPrep instrument 468 
(Fluidigm) and STRT/C1 protocol, as previously described (Zeisel et al., 2015; Goldmann et 469 
al., 2016). Each single cell was imaged and manually curated, and only single healthy-470 
looking cells without debris were used for the analyses. Data analysis was performed as 471 
previously described (doi: DOI: 10.1126/science.aaa1934) using the BackSPIN algorithm. 472 
Single-cell RNA-seq for mouse microglia: Microglia were FACS-sorted from up to six 473 
different CNS regions of healthy and diseased brains (see gating strategy shown in 474 
supplementary Fig. 1) into a 384-well plate containing a lysis buffer, and were analysed using 475 
Smart-seq2 method. Expression profiles were obtained as absolute cDNA molecule counts 476 
using the STAR aligner (doi: 10.1093/bioinformatics/bts635) to align raw sequences in 477 
conjunction with feature counts as part of the subread package (doi: 10.1093/nar/gkt214) to 478 
obtain gene counts. Further analysis and data normalization was performed using the 479 
RaceID package (Herman JS 2018). Clusters with more than ten individual cells were 480 
retained for further analysis and normalized to “transcripts per million” to compensate for 481 
differences in total transcriptome size between cell types. Heatmaps were generated using 482 
the online software (https://academic.oup.com/bioinformatics/article/32/18/2847/1743594). 483 
Analysis of microglia from human brains: Human microglia were isolated from 484 
histologically healthy brain tissue removed during brain surgery for the treatment of epilepsy 485 
in five individuals (these tissues are not part of the epileptic region but are routinely removed 486 
to surgically access the epileptic lesion). Histopathological changes were excluded by an 487 
experienced neuropathologist, and only histologically healthy specimens were included in 488 
this study. Microglia were FACS-sorted into a 384-well plate containing lysis buffer. Single-489 
cell RNA sequencing was conducted using the Cel-Seq2 protocol and processed as 490 
previously described (46). Libraries were sequenced on an Illumina HiSeq 3000 System in 491 
high output run mode at a depth of ~200,000 reads per cell. Paired end reads were aligned 492 
to the transcriptome using bwa with default parameters and all isoforms of the gene counted 493 
to a single gene locus (47). Reads that were not uniquely mapped were discarded. The left 494 
read contained the barcode information (6 bases corresponded to the cell specific barcode + 495 
6 bases representing the unique molecular identifier (UMI)) and a polyT stretch and was 496 
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omitted from quantification. The corresponding right read was mapped to the ensemble of all 497 
gene loci and used for quantification. Genes were counted based on the number of UMIs per 498 
transcript from a given gene locus. The number of UMIs was converted to transcript counts 499 
based on a binomial distribution (48). The aggregate of transcript counts with the same cell 500 
barcode represented the transcriptome of an individual cell. Data analysis, normalization and 501 
visualization was performed using the RaceID2 package (doi:10.1038/nature14966). Clusters 502 
with more than 15 individual cells were retained for further analysis and transcript counts 503 
were normalized by down sampling to 1500. Detailed human patient information is provided 504 
in Suppl. Table.1. 505 
Flow cytometry: After transcardial perfusion with PBS, brains were roughly minced and 506 
homogenized with a potter in HBSS containing 15 mM HEPES buffer and 0.54 % glucose. 507 
Whole-brain homogenate was separated by 70/37/30 % layered Percoll gradient 508 
centrifugation at 800 g for 30 min at 4 °C (no brake). The CNS macrophages containing 509 
interphase was then collected and washed once with PBS containing 2 % FCS and 10mM 510 
EDTA before staining. Cells were stained with primary antibodies directed against CD11b 511 
(M1/70, BioLegend), CD45 (30-F11, BD Biosciences), Ly6C (AL-21, BD Biosciences) and 512 
Ly6G (1A8, BD Biosciences) for 20 min, and CD206 (C068C2, BioLegend) for 45 min at 4 513 
°C. After washing, cells were sorted using a MoFlo Astrios (Beckman Coulter). Viable cells 514 
were gated by staining with Fixable Viability Dye (eBioscience). Data were acquired with 515 
FACSDiva software (Becton Dickinson). Post-acquisition analysis was performed using 516 
FlowJo software, version X.0.7. 517 
Immunohistochemistry and cell quantifications: For juvenile and adult mice, after 518 
transcardial perfusion with PBS, brains were fixed for 4 h in 4 % PFA, dehydrated in 30 % 519 
sucrose and embedded in Tissue-Tek® O.C.T. compound (Sakura Finetek Germany GmbH). 520 
For embryos, isolated brains were fixed for 4 h in 4 % PFA, dehydrated in 30 % sucrose and 521 
embedded in Tissue-Tek® O.C.T. compound. Cryosections were obtained as described 522 
previously (26). Sections were then blocked with PBS containing 5 % bovine serum albumin 523 
and permeabilized with 0.1% Triton-X 100 in blocking solution. Primary antibodies were 524 
added over night at a dilution of 1:500 for Iba-1 (ab178846, Abcam), 1:200 for APOE 525 
(AB947, Millipore), 1:200 for CTSB (ab58802, Abcam) 1:200 for CST3 (AF1238, R&D 526 
Systems), 1:200 for SPARC (IC942G, R&D Systems), 1:400 for NeuN (MAB377, Millipore), 527 
1:1000 for APC (OB80, Millipore), 1:100 for Aldh1l1 (ab87117, Abcam), 1:500 for TMEM119 528 
(ab209064, abcam), 1:500 for SPP1 (ab8448, abcam), 1:200 for CD74 (In1/CD74, 529 
BioLedend) at 4°C. Secondary antibodies were purchased from Thermo Fisher Scientific 530 
added as follows: Alexa Flour® 488 1:500, Alexa Flour® 568 1:500 and Alexa Fluor® 647 531 
1:500 for 2h at RT. Human tissue blocks were fixed in 4 % PFA overnight and embedded in 532 
paraffin. Sections were then blocked with PBS containing 5 % bovine serum albumin and 533 
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permeabilized with 0.1% Triton-X 100 in blocking solution. Primary antibodies were treated 534 
over night at a dilution of 1:500 for Iba-1 (ab178846, Abcam; ab139590, Abcam; NB100-535 
1028, Novus Biologicals), 1:200 for SPP1 (HPA027541, Sigma), 1:500 for CD74 (ab9514, 536 
abcam), 1:500 for CTSD (ab6313, abcam), 1:200 for MRP14 (T-1026, BMA Biomedicals; LS-537 
B12844, LSBio). Secondary antibodies were purchased from Thermo Fisher Scientific added 538 
as follows: Alexa Flour® 405 1:500, Alexa Flour® 488 1:500, Alexa Flour® 568 1:500 and 539 
Alexa Fluor® 647 1:500 for 2 h at RT. Coverslips were mounted with/without ProLongTM 540 
Diamond Antifade Mountant with DAPI (Thermo Fisher Scientific). Images were taken using 541 
a conventional fluorescence microscope (Olympus BX-61 with a color camera (Olympus 542 
DP71) or BZ-9000 (Keyence, Osaka, Japan) and the confocal pictures were taken with 543 
Fluoview FV 1000 (Olympus) using a 20 x 0.95 NA (XLUMPlanFL N, Olympus).  544 
Facial nerve axotomy and cuprizone model of demyelination and remyelination: Facial 545 
nerve was injured as described previously (13, 37). Briefly, mice were anesthetized by 546 
subcutaneous injection of a mixture of ketamine (50 mg/kg) and xylazine (7.5 mg/kg), and 547 
the right facial nerve was transected at the stylomastoid foramen, resulting in ipsilateral 548 
whisker paresis. Cuprizone treatment was used as a model of toxic, demyelination and 549 
remyelination (37, 49). For demyelination, mice were fed for 5 weeks with 0.45 % (wt/wt) 550 
cuprizone (Sigma, St. Louis, MO) in the ground breeder chow. For remyelination, the 551 
cuprizone diet was discontinued after 5 weeks and animals were maintained for further 5 552 
weeks under normal diet to allow spontaneous remyelination. Untreated age-matched mice 553 
were used as control. 554 
Single molecule fluorescent in situ hybridization (smFISH): Mice were perfused with 555 
PBS, followed by 4% paraformaldehyde (PFA). The brain tissues were harvested and 556 
immersion-fixed in 4% PFA for 3 h, and subsequently were put into 30% sucrose in 4% PFA 557 
at 4°C overnight, and embedded in OCT for sectioning, frozen on dry ice and stored at -80°C 558 
until used. 10-μm thick sections mounted on the glass plate were washed 3 times with PBS, 559 
and treated with pre-chilled methanol for 10 min at -20 °C. Then the slides were incubated for 560 
10 min at 70°C in Tris-EDTA (pH 8.0), and the sections were washed with SSC 2X and 561 
incubated for 4 hr with hybridization buffer containing 250 nM fluorescent label probes (LGC 562 
Biosearch Technologies) at 38.5°C. After 4 times washing with 20% formamide wash buffer 563 
containing SSC 2X, the slides were mounted with Prolong Gold containing DAPI. Stack 564 
Images were taken using a Olympus BX-61 microscope.  565 
Gene ontology (GO) enrichment analysis: The defined differentially regulated genes were 566 
analyzed using the software (available from http://metascape.org/gp/#/main/step1). 567 
Pairwise correlation analysis: Comparison between human and mouse data was 568 
performed by selecting all genes found to differentially expressed by RaceID (adjusted 569 
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p<0.01, log2FC > 1) in any of the identified clusters. For genes from the human dataset 570 
mouse orthologs were identified from the NCBI HomoloGene database 571 
(https://www.ncbi.nlm.nih.gov/homologene), using the annotationTools R package (Kuhn A 572 
2008); the same was done to identify human orthologs for the murine genes. All human 573 
genes with a ortholog in the mouse set as well as all murine genes with an ortholog in the 574 
human set were kept. Canonical Cluster Analysis as implemented in the Seurat package 575 
(Butler A 2018) was then performed on the 768 common genes identified in this manner. 576 
Statistical analysis: Statistical significance was determined using one-way ANOVA with 577 
post hoc Tukey Multiple Comparison test using GraphPad Prism 5.04 software.    578 
579 
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FIGURE LEGENDS  580 
 581 
Figure 1: Unbiased single-cell RNA-seq of CNS cells reveals specific profiles of murine 582 
microglia and pvMΦ. 583 
(a) Schematic diagram showing the isolation of single CNS cells from juvenile (3 weeks of 584 
age) mice for unbiased sampling and single-cell RNA-seq (scRNA-seq).  585 
(b) Cluster analysis using t-SNE of 3,047 individual cells measured by single-cell RNA 586 
sequencing and bi-clustering. Each dot represents an individual cell. The populations of 587 
microglia and perivascular macrophages (pvMΦ) are marked by a dotted line. Vsmc: 588 
vascular smooth muscle cell. 589 
(c) Heat map showing clustering of 2,996 single cells, featuring 49 most variable genes. 590 
Selected marker genes enriched in each cell-type representing expression levels of 591 
selected known and novel markers are shown on the right. 592 
(d) t-SNE clustering plots of individual microglia and perivascular macrophages (pvMΦ) 593 
showing distinct gene expression pattern between the two cell types in the juvenile CNS 594 
(326 cells). Each dot represents a single cell. Microglia are depicted as circles, pvMΦ as 595 
triangles.  596 
 597 
Figure 2: Comprehensive analysis of microglial diversity by single-cell RNA-598 
sequencing.   599 
(a) Illustration depicting the workflow for the isolation of microglia from different CNS regions 600 
of embryonic (embryonic day E16.5) and juvenile (3 weeks of age) and adult (16 weeks) 601 
mice during homeostasis and during pathology, namely facial nerve axotomy (FNX) 602 
cuprizone-mediated demyelination for scRNA-seq.  603 
(b) t-SNE plot showing all analyzed microglia cells from different conditions tested in this 604 
study. Each dot represents a single cell.     605 
(c) t-SNE plot depicting 13 clusters for all different conditions. Colors represent each cluster 606 
(C).  607 
 608 
Figure 3: Identification of spatiotemporal subclasses of microglia in the mouse.  609 
(a) t-SNE plot of 2,966 individual microglia isolated at different time points of development. 610 
Each dot represents a single cell. Colors correspond to the time points investigated. 611 
(b) t-SNE plot depicting ten major and three minor microglia clusters at three different 612 
developmental stages. Each dot represents a single cell. Colors represent each cluster 613 
(C). 614 
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(c) Heat map of top differentially regulated genes that were up- or down-regulated  in each 615 
cluster, including genes such as Malat1, Selplg, Tmem119, Sparc, Cst3, Ctsd, Lamp1, 616 
Ctsb, Apoe, Tmsb4x, Eef1a1 and Rpl4.        617 
(d) t-SNE plots depicting regional distribution of transcripts from 2966 individual microglia at 618 
different developmental time points. Each dot represents a single cell.  619 
(e)  Distribution of microglia clusters among different CNS regions during embryonic and 620 
postnatal stages. Colors represent distinct clusters. 621 
 622 
Figure 4: Characteristics of microglial subsets during development.  623 
(a) t-SNE plots depicting the expression kinetics of the microglial core genes Tmem119, 624 
Selplg and Slc2a5 during ontogeny. Upper right cloud shows E16.5 microglia whereas 625 
the lower left cloud represents microglia from juvenile and adult mice. Color key indicates 626 
the expression levels. 627 
(b) t-SNE plots of embryo-enriched microglia transcripts for Ctsb, Apoe and Tmsb4x.  628 
(c) Representative immunofluorescence images for apolipoprotein (Apo)E, cathepsin B 629 
(CTSB) and ionized calcium-binding adapter (Iba)1 in the embryonic forebrain and 630 
juvenile cortex. Dotted frame 1 indicates ApoE-CTSB-Iba1+ embryonic microglia 631 
(representing clusters C3, C6). Frame 2 illustrates ApoE-CTSB+Iba1+ embryonic 632 
microglia (C1, C2) whereas frame 3 shows ApoE+CTSB+Iba1+ triple-positive embryonic 633 
microglia (C1). Dotted frame 4 depicts ApoE+CTSB-Iba1+ embryonic microglia (C4, C5). 634 
Frame 5 illustrates ApoE-CTSB-Iba1+ microglia (white arrowheads) found at the juvenile 635 
stage. Yellow arrowheads indicate ApoE+Iba1- cells in the juvenile brain. Representative 636 
pictures out of four investigated mice are shown. Scale bars: 50 µm (overview), 30 µm 637 
(insert). 638 
(d) Quantification of ApoE and CTSB immunoreactivities in Iba1+ microglia from different 639 
CNS regions during development. Bars represent means ± SEM from four animals (541-640 
853 microglia per region).  641 
(e) t-SNE plots-based distribution of Cst3 and Sparc transcripts in microglia. Color keys 642 
indicate the expression levels. 643 
(f) Representative immunofluorescence images for cystatin C (CST3), secreted protein 644 
acidic and rich in cysteine (SPARC) and Iba1 in the embryonic forebrain, juvenile and 645 
adult cortex. Frame 1 indicates CST3+SPARC+Iba1+ microglia (representing clusters C9, 646 
C10) whereas frame 2 highlights CST3-SPARC-Iba1+ microglia (C7) during adulthood. 647 
Representative pictures out of four investigated mice are shown. Scale bars: 50 µm 648 
(overview), 20 µm (insert). 649 
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(g) Quantification of CST3 and SPARC immunopositivity in microglia from different regions 650 
of the CNS at distinct developmental time points. Bars represent means ± SEM from four 651 
animals (569 - 1961 microglia per region). 652 
 653 
Figure 5: Specific disease-associated microglia populations with distinct kinetics 654 
during demyelination and neurodegeneration.  655 
(a) Projection of 1,564 single microglia isolated from different CNS regions during 656 
homeostasis or FNX or cuprizone treatment as t-SNE plot. 657 
(b) Heat map of top differentially regulated genes that were up- or down-regulated in each 658 
cluster. Highest differentially expressed genes are highlighted. 659 
(c) t-SNE plot exhibiting 13 clusters for the 1,564 individual microglia isolated from different 660 
CNS regions during homeostasis or FNX or cuprizone treatment.  661 
(d) Left: Kinetics of facial nucleus (FN) microglia subpopulation on a t-SNE map either 662 
untreated (FN-normal) or after 3 days post FNX (FNX-d3) or 7 days post FNX (FNX-d14), 663 
respectively. Right: Histogram displaying proportion of microglia clusters either untreated 664 
(FN-normal) or after FNX-d3 or FNX-d14. 665 
(e) Clustering of the Ctsc gene expression following FNX. Expression of Ctsc is found to be 666 
upregulated in C11 at FNX-d3. The color key indicates the expression levels. Insert: 667 
close-up of the C11. 668 
(f) Persistent transition of corpus callosum (CC) microglia population on a t-SNE map before 669 
(CC-normal) and after demyelination (CC-Demyelination) or remyelination (CC-670 
Remyelination). Close-ups reveal distribution of clusters after demyelination and 671 
remyelination. Right: Histogram showing long-lasting changes in microglia populations 672 
following cuprizone treatment. 673 
(g) Kinetics of Apoe, Cst7 and Cybb expression after cuprizone challenge displayed in t-SNE 674 
plots. Color keys represent the respective expression levels. 675 
(h) t-SNE plots for Tmem119, Spp1, Cd74 after cuprizone treatment. Tmem119 is 676 
downregulated following treatment, whereas Spp1 is upregulated in C12, and Cd74 677 
mRNA is increased in C13. Color keys indicate the expression levels. 678 
(i) Left: representative immunofluorescence images for osteopontin (secreted 679 
phosphoprotein 1, SPP1), CD74 and Iba1 in the normal and demyelinated corpus 680 
callosum. Arrowheads indicate SPP1-CD74-Iba1+ (white arrowheads), SPP1+CD74-Iba1+ 681 
(red arrowheads), and SPP1-CD74+Iba1+ (blue) parenchymal microglia, respectively. 682 
Representative pictures out of three or four investigated mice are shown. Right: 683 
Quantification thereof. Bars represent means ± SEM of three to four animals (437 - 825 684 
microglia per condition). Each symbol represents one animal. Scale bars: 30 µm. 685 
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(j) Left: typical immunofluorescence pictures for transmembrane protein (TMEM) 119, CD74 686 
and Iba1 in the normal and demyelinated corpus callosum. Arrowheads show 687 
TMEM119+CD74-Iba1+ (white arrowhead), TMEM119-CD74-Iba1+ (red) and TMEM119-688 
CD74+Iba1+ (blue) parenchymal microglia. Representative pictures out of four 689 
investigated mice are shown. Right: Quantification thereof. Bars represent means ± SEM 690 
of four animals (808 - 1024 microglia per condition). Each symbol represents one animal. 691 
Scale bars: 30 µm. 692 
 693 
Figure 6: Presence of distinct subclasses of microglia in healthy human and MS brains. 694 
(a) t-SNE plot of 1,180 individual human microglia isolated from five individual non-695 
pathological brains depicts four major clusters (HHu-C1-4). HHu-C: healthy human 696 
microglia cluster. Each dot represents a single cell. Colors correspond to each cluster.   697 
(b) Heat map of the top differentially regulated genes that were up- or down-regulated in 698 
each cluster, including genes such CST3, P2RY13, CCL4, CCL2, EGR2 and EGR3.  699 
(c) Bar graphs representing the relative abundance of microglia cells in the respective 700 
clusters from five individual non-pathological brains. Colors represent distinct clusters. 701 
(d) t-SNE plots for CST3, CCL4 and EGR2 mRNA expression. CCL4 and EGR2 are 702 
enriched in the Hu-C4.  703 
(e) t-SNE plot of 422 individual human microglia isolated from five individual non-704 
pathological brains and five patients with early active multiple sclerosis (MS). Each dot 705 
represents a single cell. Colors correspond to each condition or patient. 706 
(f) t-SNE plot depicting ten major clusters (Hu-C1-10) of microglia from healthy and 707 
diseased individuals. Each dot represents a single cell. Colors correspond to each 708 
cluster. 709 
(g) Heat map of all differentially regulated genes that were up- or down-regulated in each 710 
cluster.  711 
(h) Bar graphs representing the relative abundance of microglia in each cluster from healthy 712 
and individual MS patients. Colors represent individual patients or conditions. 713 
(i) t-SNE plots representing the core signature genes for lymphocytes, myeloid cells and 714 
monocytes in the brains from MS patients. Color keys reflect the expression levels.  715 
(j) t-SNE plots of the microglia cluster representing the top five enriched genes for each 716 
cluster. Homeostatic microglial genes are enriched in the microglia clusters Hu-C5-7, 717 
whereas Hu-C4 is characterized by the expression of proinflammatory molecules CCL4 718 
and CCL2.  Hu-C2, Hu-C3 and Hu-C8 are present in microglia from MS patients.    719 
(k) Immunofluorescence images for TMEM119 and Iba1 in healthy or MS patient brains. 720 
Arrowheads indicate TMEM119+Iba1+ cells (filled) in the healthy brains, and TMEM119-721 
Iba1+ microglia (open) during MS. Scale bar: 50 µm.  722 
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(l) Representative immunofluorescence pictures for Iba1+MRP14- (indicating microglia) and 723 
Iba1+MRP14+ cells (representing infiltrating early activated monocytes) in the normal and 724 
MS brain. Inserts show microglia (first row) and monocytes (second row) in the MS 725 
lesion. Right: Quantification thereof. Bars represent means ± SEM. Each symbol 726 
represents one patient. Scale bars: 50 µm (overview), 4 µm (insert). 727 
(m) Upper panel: representative immunofluorescence images for SPP1, CTSD, Iba1 and 728 
MRP14 indicating microglia subsets in normal and MS brains. Representative pictures 729 
out of four individuals were chosen. Dotted frames represent SPP1-CTSD+MRP14-Iba1+ 730 
microglia (1) and SPP1+CTSD-MRP14-Iba1+ microglia (2). Scale bars: 50 µm (overviews), 731 
20 µm (inserts). Lower panel: Quantification of microglia immunoreactivities in healthy or 732 
MS brains. Percentages indicate the relation of MRP14-Iba-1+ microglia subsets in 733 
individual brains. 153 - 163 microglia per patient were examined.  734 
(n) Upper: Immunofluorescence pictures for SPP1, CD74, Iba1 and MRP14 for the 735 
characterization of microglia cluster in healthy and MS brains. Colored dotted frames 736 
indicate SPP1-CD74+MRP14-Iba1+ (white), SPP1+CD74-MRP14-Iba1+ (yellow) 737 
parenchymal microglia, respectively. Representative pictures out of four individuals are 738 
shown. Scale bars: 50 µm (overviews), 20 µm (inserts). Lower left: Quantification of 739 
microglia immunopositivities in healthy or MS brains. Percentages indicate the relation of 740 
MRP14-Iba-1+ microglia subsets in individual brains. 152 - 200 microglia per patient were 741 
investigated. Lower right: Distribution of SPP1 and CD74-reactive Iba1+ microglia 742 
subsets in the healthy mouse corpus callosum or during cuprizone-induced de-and 743 
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EXTENDED DATA 750 
 751 
Extended Data Figure 1: Molecular characterization of rodent microglia and 752 
perivascular macrophages. 753 
(a) Heat map showing clustering of 2,996 single cells, featuring ten selected genes enriched 754 
both in microglia and perivascular macrophages (pvMΦ) obtained from juvenile (3 weeks 755 
of age) mice. 756 
(b) Gene ontology (GO)-term enrichment analysis for the 274 top genes enriched for 757 
microglia. 758 
(c) GO-term enrichment analysis for the top 317 genes enriched for pvMΦ. 759 
 760 
Extended Data Figure 2: Microglial subpopulations in mice with distinct gene 761 
expression during development. 762 
(a) Distribution of Malat1 gene expression in a t-SNE plot. Color keys represent the 763 
respective expression levels. Upper left cloud represents embryonic microglia population 764 
whereas lower right cloud combines both juvenile and adult microglia as shown in Fig. 2b. 765 
(b) Left: smFISH for Malat1 and Cx3cr1 shows the kinetics of Malat1+ microglia during 766 
development. Scale bar: 10 µm. Representative pictures out of two investigated adult 767 
mice are shown. Yellow arrowhead and white indicate Malat1+Cx3cr1+ microglia and 768 
Malat1+Cx3cr1- non-microglia cells, respectively. Right: Frequency of Malat1+ microglia 769 
in the forebrain or cortex during development. Bar represents mean ± SEM of 120 770 
studied cells from three animals per time points. 771 
(c) t-SNE plot of Ctsd and Lamp1 gene expression that were enriched in C1 and C2 clusters 772 
as shown in Fig. 2c. 773 
(d) t-SNE plot of Eef1a1 and Rpl4 gene expression that were enriched in C6 cluster as 774 
shown in Fig. 2c. 775 
 776 
Extended Data Figure 3:  Cst3 is enriched in adult microglia.   777 
(a-c) Representative sections of the cortex from adult mice using immunofluoresence for 778 
cystatin C (CST3, green), NeuN for neurons (red, a), adenomatous polyposis coli (APC) 779 
for oligodendrocytes (red, b), respectively. The astrocyte marker Aldh1l1 (red, c) 780 
combined with CST3 was used on the hippocampal sections. Scale bars: 50 μm 781 
(overviews) and 20 μm (magnifications). Representative pictures out of three investigated 782 
mice are shown.  783 
(d) Quantification of CST3 immunoreactivity in the brain of adult mouse. Bar represents 784 
mean ± SEM of three animals (393 microglia, 1817 neurons, 298 oligodendrocytes, 461 785 
astrocytes). 786 
 787 




Extended Data Figure 4: Molecular characterization of microglia subpopulations 789 
during de- and remyelination.    790 
t-SNE plots showing expression of Axl, Igf1, Lyz2, Itgax, Gpnmb, Apoc1 (a), Fam20c Ccl6, 791 
Psat1, Ank (b), Fn1 (c), Spp1 (e), Cybb (g), H2-Aa and H2-Ab1 (i), Ccl4 (j) transcripts after 792 
cuprizone challenge. Genes shown in (a) were upregulated in both de-and remyelination, 793 
whereas genes depicted in (b, c, e) or (g, i) were increased in demyelination-associated 794 
cluster Adt-C5, C6, or in the remyelination- associated Adt-C7, C8, respectively. Color keys 795 
represent the respective expression levels. (d) Left and middle panels: single-molecule 796 
fluorescent in situ hybridization (smFISH) for Fn1 and Cx3cr1 reveals subpopulations of 797 
microglia after 5-week cuprizone treatment in the corpus callosum. “1” indicates Fn1+Cx3cr1+ 798 
microglia (yellow arrowheads: Fn1 mRNA). “2” indicates Fn1-Cx3cr1+ microglia. Scale bar: 10 799 
µm (overviews) or 3 µm (inserts). Representative pictures out of three investigated mice are 800 
shown. Blank arrowheads in the picture of control mice indicate non-specific signals. Right 801 
panel: percentage of Fn1+ Cx3cr1+ microglia in the corpus callosum. Bar represents mean ± 802 
SEM of three animals (168 investigated cells). (e) Spp1 mRNA expression after cuprizone 803 
challenge. Expression of Spp1 is found to be upregulated in Adt-C5 and C6. The color key 804 
indicates the expression levels. (f) Left and middle panels: smFISH for Spp1 and Cx3cr1 805 
reveals subpopulations of microglia after 5-week cuprizone treatment in the corpus callosum. 806 
“1” indicates Spp1+Cx3cr1+ microglia (yellow arrowheads: Spp1 mRNA). “2” indicates Spp1-807 
Cx3cr1+ microglia. Scale bars: 10 µm (overviews) and 3 µm (inserts). Representative pictures 808 
out of three investigated mice are shown. Right panel: percentage of Spp1+Cx3cr1+ microglia 809 
in the corpus callosum. Bar represents mean ± SEM of three animals (165 investigated cells). 810 
(g) t-SNE plot depicting Spp1 expression after cuprizone challenge. The color key indicates 811 
the expression levels (h) Left and middle panels: smFISH for Cybb and Cx3cr1 reveals 812 
subpopulations of microglia after 5 weeks cuprizone treatment in the corpus callosum. “1” 813 
indicates Cybb+Cx3cr1+ microglia (yellow arrowheads: Cybb mRNA). “2” indicates Cybb-814 
Cx3cr1+ microglia. Scale bars: 10 µm (overviews) and 3 µm (inserts). Representative pictures 815 
out of three investigated mice are shown. Right panel: percentage of Cybb+Cx3cr1+ microglia 816 
in the corpus callosum. Bar represents mean ± SEM of three animals (165 investigated cells).  817 
The color key represents the expression levels. 818 
 819 
Extended Data Figure 5:  Microglial subtypes in healthy human brains. 820 
(a) t-SNE plot of 1180 human microglia showing the distribution of individual microglia from 821 
five patients. Each dot represents a single cell. Different colors indicate different patients,  822 
(b) Heat map showing the distribution of the healthy human clusters (HHu-C) in each 823 
individual patient.  824 
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(c) t-SNE plot showing the expression of P2RY13. Each dot represents a single cell. Color 825 
codes represent expression levels. 826 
 827 
Extended Data Figure 6:  Detailed neuropathological characterization of human MS 828 
lesions. 829 
Histology of the MS brains (MS-1 patient until MS-5 patient) using hematoxylin and eosin 830 
(H&E), luxol fast blue (LFB-PAS), 2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNPase), and 831 
myelin basic protein (MBP) for myelin, human leukocyte antigen – DR isotype (HLA-DR) and 832 
CD68 for myeloid cells, CD3 for T cells, CD20 for B cells and Bielschowsky (Biel) for axons. 833 
Scale bar: 50 µm. Lesions are typical early active MS lesions according to the standard 834 
classification system (50). 835 
 836 
Extended Data Figure 7:  Molecular profile of microglia subsets during MS. 837 
(a-e) t-SNE plots of genes enriched in cluster Hu-C5-7 (a), Hu-C2 (b), Hu-C3 (c), Hu-C4 838 
(d), Hu-C8 (e) are shown. Color codes represent expression levels. 839 
(f) t-SNE plots depicting genes upregulated in the clusters Hu-C2, Hu-C3 and Hu-C8. Color 840 
codes represent expression levels. 841 
(g) t-SNE plots of genes that were upregulated in the disease-associated microglia subsets 842 
in the mouse demyelination model, but not in the microglia in the MS patient brains. Color 843 
codes represent expression levels.  844 
 845 
Extended Data Figure 8: Pairwise correlation analysis of scRNA-seq data from mouse 846 
and human microglia. 847 
(a) Canonical correlation analysis (Seurat alignment procedure) visualizing shared 848 
correlation structures (i.e., canonical correlation vectors, CC) between mouse and human 849 
data sets. Each dot represents single cell.   850 
(b) CC Plot of cells assigned as mouse C7-C13 and human Hu-C1-C10. Mouse 851 
demyelination-related microglia clusters (C12 and C13) are transcriptionally close to 852 
human MS-associated microglia clusters (Hu-C2, Hu-C3 and Hu-C8). Each dot 853 
represents single cell.   854 
(c)  Violin plots depicting a shared gene correlation structure that is conserved between 855 
mouse and human clusters. 856 
 857 
 858 
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SUPPLEMENTAL FIGURES AND TABLE 864 
 865 
Supplementary Figure 1:  FACS gating strategy for microglia isolation. 866 
CNS cells were gated for G1 and G2 (singlets), followed by being gated for living cell (G3, 867 
fixable viability dye), CD45intCD11b+ (G4), Ly6C-Ly6G- (G5), and CD206- (G6). 868 
 869 
Supplementary Figure 2:  related to figure 2-5  870 
t-SNE plots depicting single microglia from the replicates from different CNS regions of 871 
individual embryos, juvenile and adult mice and diseased mice.   872 
 873 
Supplementary Figure 3:  related to figure 3 874 
Heat map of all differentially regulated genes that were up- or down-regulated in each cluster 875 
microglia during development. 876 
 877 
Supplementary Figure 4:  related to figure 5 878 
Heat map of all differentially regulated genes that were up- or down-regulated in each cluster. 879 
 880 
Supplementary Figure 5:  related to figure 6 881 
Heat map of top 68 differentially regulated genes that were up- or down-regulated in each 882 
cluster of healthy human microglia. 883 
 884 
Supplementary Figure 6:  related to figure 6 885 
Heat map of top 148 differentially regulated genes that were up- or down-regulated in each 886 
cluster of both healthy and MS-patient microglia. 887 
 888 
Supplementary Table 1: 889 
Sheet 1: Information on mice and cells used in each scRNA-seq analysis including 890 
genotype, strain, sex, condition, age, CNS region and cell numbers.   891 
Sheet 2: Details on patients and cells used in each scRNAseq analysis including sex, 892 
condition, age, CNS region and cell numbers.    893 
Microglial heterogeneity by single-cell RNA-seq 
 
 32
Reference List 894 
 895 
 1.  R. M. Ransohoff, V. H. Perry, Annu. Rev Immunol. 27, 119 (2009). 896 
 2.  M. Colonna, O. Butovsky, Annu. Rev. Immunol. 35, 441 (2017). 897 
 3.  J. Herz, A. J. Filiano, A. Smith, N. Yogev, J. Kipnis, Immunity. 46, 943 (2017). 898 
 4.  M. Prinz, D. Erny, N. Hagemeyer, Nat. Immunol. 18, 385 (2017). 899 
 5.  F. Ginhoux, S. Jung, Nat. Rev. Immunol. 14, 392 (2014). 900 
 6.  C. Schulz et al., Science 336, 86 (2012). 901 
 7.  K. Kierdorf et al., Nat. Neurosci 16, 273 (2013). 902 
 8.  T. Goldmann et al., Nat. Immunol. 17, 797 (2016). 903 
 9.  K. Molawi et al., J. Exp. Med. 211, 2151 (2014). 904 
 10.  N. Mossadegh-Keller et al., J. Exp. Med. 214, 2829 (2017). 905 
 11.  S. Ensan et al., Nat. Immunol. (2015). 906 
 12.  N. Hagemeyer et al., Acta Neuropathol. (2017). 907 
 13.  T. L. Tay et al., Nat. Neurosci. 20, 793 (2017). 908 
 14.  P. Fuger et al., Nat. Neurosci. 20, 1371 (2017). 909 
 15.  K. Askew et al., Cell Rep. 18, 391 (2017). 910 
 16.  A. C. Wendeln et al., Nature 556, 332 (2018). 911 
 17.  D. Erny et al., Nat. Neurosci. 18, 965 (2015). 912 
 18.  J. Bruttger et al., Immunity. 43, 92 (2015). 913 
 19.  S. E. Hickman et al., Nat. Neurosci. (2013). 914 
 20.  K. J. Doorn et al., Front Cell Neurosci. 9, 84 (2015). 915 
 21.  K. Grabert et al., Nat. Neurosci. 19, 504 (2016). 916 
 22.  K. Sharma et al., Nat. Neurosci. 18, 1819 (2015). 917 
 23.  K. Kierdorf, N. Katzmarski, C. A. Haas, M. Prinz, PLoS. One. 8, e58544 (2013). 918 
 24.  A. Wlodarczyk et al., EMBO J. (2017). 919 
 25.  O. Matcovitch-Natan et al., Science 353, aad8670 (2016). 920 
 26.  T. Goldmann et al., EMBO J. 34, 1612 (2015). 921 
 27.  S. Krasemann et al., Immunity. 47, 566 (2017). 922 
Microglial heterogeneity by single-cell RNA-seq 
 
 33
 28.  M. J. T. Stubbington, O. Rozenblatt-Rosen, A. Regev, S. A. Teichmann, 923 
Science 358, 58 (2017). 924 
 29.  D. Gosselin et al., Science 356, (2017). 925 
 30.  T. F. Galatro, I. D. Vainchtein, N. Brouwer, E. W. G. M. Boddeke, B. J. L. 926 
Eggen, Methods Mol. Biol. 1559, 333 (2017). 927 
 31.  Y. Lavin et al., Cell 159, 1312 (2014). 928 
 32.  H. Mathys et al., Cell Rep. 21, 366 (2017). 929 
 33.  H. Keren-Shaul et al., Cell 169, 1276 (2017). 930 
 34.  A. Zeisel et al., Science 347, 1138 (2015). 931 
 35.  D. Grun et al., Cell Stem Cell 19, 266 (2016). 932 
 36.  M. Prinz, J. Priller, Nat. Rev. Neurosci. 15, 300 (2014). 933 
 37.  A. Mildner et al., Nat. Neurosci. 10, 1544 (2007). 934 
 38.  E. N. Benveniste, J. Mol. Med. (Berl) 75, 165 (1997). 935 
 39.  W. Bruck et al., Ann. Neurol. 38, 788 (1995). 936 
 40.  O. Butovsky et al., Nat. Neurosci. 17, 131 (2014). 937 
 41.  L. J. Lawson, V. H. Perry, S. Gordon, Neuroscience 48, 405 (1992). 938 
 42.  Y. Wang et al., Nat. Immunol. 13, 753 (2012). 939 
 43.  L. M. De Biase et al., Neuron 95, 341 (2017). 940 
 44.  T. Zrzavy et al., Brain 140, 1900 (2017). 941 
 45.  A. Mildner, H. Huang, J. Radke, W. Stenzel, J. Priller, Glia 65, 375 (2017). 942 
 46.  T. Hashimshony et al., Genome Biol. 17, 77 (2016). 943 
 47.  H. Li, R. Durbin, Bioinformatics. 26, 589 (2010). 944 
 48.  D. Grun, L. Kester, O. A. van, Nat. Methods 11, 637 (2014). 945 
 49.  J. Raasch et al., Brain 134, 1184 (2011). 946 
 50.  C. Lucchinetti et al., Ann. Neurol. 47, 707 (2000). 947 
 948 
 949 







